Impact of decreasing copayments on medication adherence within a disease management environment

被引:240
作者
Chernew, Michael E. [1 ]
Shah, Mayur R. [2 ]
Wegh, Arnold [3 ]
Rosenberg, Stephen N.
Juster, Iver A.
Rosen, Allison B. [4 ,5 ]
Sokol, Michael C. [6 ]
Yu-Isenberg, Kristina [7 ]
Fendrick, A. Mark [8 ]
机构
[1] Harvard Univ, Sch Med, Boston, MA 02115 USA
[2] ActiveHlth Management, New York, NY USA
[3] SAS Programmer Informat, Atlanta, GA USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA
[6] GlaxoSmithKline Inc, HMI, Montvale, NJ USA
[7] GlaxoSmithKline Inc, HMi, Res Triangle Pk, NC USA
[8] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA
关键词
D O I
10.1377/hlthaff.27.1.103
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This paper estimates the effects of a large employer's value-based insurance initiative designed to improve adherence to recommended treatment regimens. The intervention reduced copayments for five chronic medication classes in the context of a disease management (DM) program. Compared to a control employer that used the same DM program, adherence to medications in the value-based intervention increased for four of five medication classes, reducing nonadherence by 7-14 percent. The results demonstrate the potential for copayment reductions for highly valued services to increase medication adherence above the effects of existing DM programs.
引用
收藏
页码:103 / 112
页数:10
相关论文
共 17 条
[11]   Pharmacy benefits and the use of drugs by the chronically ill [J].
Goldman, DP ;
Joyce, GF ;
Escarce, JJ ;
Pace, JE ;
Solomon, MD ;
Laouri, M ;
Landsman, PB ;
Teutsch, SM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (19) :2344-2350
[12]  
Goldman DP, 2006, AM J MANAG CARE, V12, P21
[13]  
GRUBER J, 1994, AM ECON REV, V84, P622
[14]  
HENSLEY S, 2004, WALL STREET J 0616
[15]  
Landon BE, 2007, AM J MANAG CARE, V13, P360
[16]  
Mahoney JJ, 2005, AM J MANAG CARE, V11, pS170
[17]  
RIDLEY D, 2005, PAYMENTS PROMOTION P